Scientific Editorial Board
Charles Brenner, PhD.Roy J. Carver, Chair and Head of Biochemistry; University of Iowa
Dr. Brenner is the Roy J. Carver Chair & Head of Biochemistry at the University of Iowa, as well as a founding co-director of the University of Iowa Obesity Initiative. In 2004, Brenner, then a faculty member at Dartmouth College, discovered nicotinamide riboside (NR) to be a previously unknown vitamin precursor of nicotinamide adenine dinucleotide (NAD). His team further established the longevity-promoting and sirtuin activating activity of NR in 2007 and was the first to demonstrate human oral availability of NR as an NAD boosting compound. Considered the world’s leading authority on NAD, he has published more than 40 scientific articles and patent applications on the roles of NR and NAD metabolism in model systems and humans. His laboratory continues to dissect the mechanisms and targets of NR and its impact on human health.
Roger Kornberg, PhD.Stanford Medical School professor; Nobel Prize winner – Chemistry 2006
Dr. Kornberg, is professor of structural biology at Stanford Medical School. He was awarded the Nobel Prize in Chemistry in 2006 for his research on the molecular basis of eukaryotic transcription. Dr. Kornberg earned his bachelor’s degree in chemistry from Harvard University in 1967 and his PhD in chemical physics from Stanford in 1972. He became a postdoctoral fellow at the Laboratory of Molecular Biology in Cambridge, England and then an assistant professor of biological chemistry at Harvard Medical School in 1976, before moving to his present position at Stanford in 1978. Kornberg’s father, the late Arthur Kornberg, was the founding chair of biochemistry at Stanford and was awarded the Nobel Prize for physiology or medicine in 1959. He was an early investigator in NAD biosynthetic pathways while at the NIH.